Adial Pharmaceuticals Inc ADIL

NAS: ADIL | ISIN: US00688A1060 30/05/2025

0,685 USD (-0,44%)

(-0,44%) 30/05/2025

Grafiek Adial Pharmaceuticals Inc

Grafiek Adial Pharmaceuticals Inc

1 dag1d -0,44%
1 week1w 2,24%
1 maand1m -0,65%
3 maanden3m -6,29%
6 maanden6m -38,29%
1 jaar1j -47,71%
5 jaar5j -56,43%

Adial Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

17 maart 2021 · Adial Founder and Chief Medical Officer Dr. Bankole Johnson Featured Guest on The Black News Channel · Persbericht

15 maart 2021 · Adial Announces Management-Led $2,100,000 Above Market Private Placement at $3.00 Per Share · Persbericht

26 februari 2021 · Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion · Persbericht

26 februari 2021 · Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants · Persbericht

25 februari 2021 · Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial · Persbericht

23 februari 2021 · Adial to File Fast Track Application for AD04 with the FDA · Persbericht

Profiel Adial Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Werknemers: 6

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe